Green Cross Medical Science Corp. engages in the manufacture and sale of in vitro diagnostic reagent products, medical equipment, and other medical supplies. It operates through following business divisions: Diagnostic Reagents, Hemodialysate, Blood Sugar Meter, and Others. The Diagnostic Reagents division provides various diagnostic reagent products and product business related to disease diagnosis, prognosis judgment, and treatment, such as COVID19 diagnostic kits, molecular diagnostics, and immunodiagnostics. The Hemodialysate division includes perfusate for artificial kidney dialysis used in patients with chronic renal failure. The Blood Sugar Meter division offers blood sugar meters, HbA1c, and lipid medical devices. The Others division consists of other home healthcare products such as thermometers and blood pressure monitors. The company was founded on December 30, 2003 and is headquartered in Yongin-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company